Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors

Blood

Volumn 87, Issue 7, 1996, Pages 2649-2658

  Aplan, Peter D ^a   Chervinsky, David S ^b   Stanulla, Martin ^b   Burhans, William C ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOUBLE STRANDED DNA; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; MELPHALAN; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME INHIBITION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMOGENESIS; MALE; PRIORITY JOURNAL; SECOND CANCER;

EID: 0030012114     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2649.bloodjournal8772649     Document Type: Article

References (42)

1. Liu L: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351, 1989
2. D'Arpa P: Determinants of cellular sensitivity to topoisomerase-targeting antitumor drugs, in Liu L (ed): DNA Topoisomerases: Topoisomerase-Targeting Drugs. New York, NY, Academic, 1994
3. Osheroff N, Corbett AH, Robinson MJ: Mechanism of action of topoisomerase II-targeted antineoplastic drugs, in Liu L (ed): DNA Topoisomerases: Topoisomerase-Targeting Drugs. New York, NY, Academic, 1994
4. Pommier Y, Bertrand R: The mechanisms of formation of chromosomal aberrations: Role of eukaryotic topoisomerases, in Kirsch IR (ed): The Causes and Consequences of Chromosomal Aberrations. Boca Raton, FL, CRC, 1993
5. Pui C-H, Riberio RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT, Crist WM: Acute myeloid leukemia in children treated with epipodophyltoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682, 1991
6. Pedersen-Bjergaard J, Philip P: Balanced transloctions involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting a DNA-topoisomerase II. Blood 78:1147, 1991
7. Levine E, Bloomfield C: Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19:47, 1992
8. Gill-Super HJ, McCabe NR, Thirman MJ, Larson RA, LeBeau MM, Pedersen-Bjergaard J, Philip P, Diaz MO, Rowley JD: Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA topoisomerase II. Blood 82:3705, 1993
9. Winick N, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, Jacaruso D, Kamen BA, Buchanan GR: Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11:209, 1993
10. Felix CA, Hosler MR, Winick NJ, Masterson M, Wilson AE, Lange BJ: ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 85:3250, 1995
11. Smith MA, Rubinstein L, Ungerleider RS: Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks. Med Pediatr Oncol 23:86, 1994
12. Maraschin J, Dutrillaux B, Aurias A: Chromosome aberrations induced by etoposide are not random. Int J Cancer 46:808, 1990
13. Berger N, Chatterjee S, Schmoter J, Helms S: Etoposide (VP 16-213)-induced gene alterations: Potential contribution to cell death. Proc Natl Acad Sci USA 88:8740, 1991
14. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, Diaz MO: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735, 1991
15. Gu Y, Nakarnura T, Alder H, Prasad R, Canaani O, Cimino G, Croce C, Canaani E: The t(4; 11) chromosome transloction of human acute leukemia fuses the ALL-1 gene, related to Drosophila Trithorax, to the AF-4 gene. Cell 71:701, 1992
16. Tkachuk D, Kohler S, Cleary M: Involvement of a homolog of Drosophila Trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691, 1992
17. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Wilman CL, Cleary ML: HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 81:3197, 1993
18. Felix CA, Reaman GH, Korsmeyer SJ, Hollis GF, Dinndorf P, Wright J, Kirsch IR: Immunoglobulin and T-cell receptor gene configuration in acute lymphoblastic leukemia of infancy. Blood 70:536, 1987
19. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
20. Davis LG, Dibner MD, Battey JF: Basic Methods in Molecular Biology. New York, NY, Elsevier, 1986
21. McCabe NR, Burnett RC, Gill HJ, Thirman MJ, Mbangkollo D, Kipiniak M, van Melle E, Ziemin-van der Poel S, Rowley JD, Diaz MO: Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc Natl Acad Sci USA 89:11794, 1992
22. Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR: Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79:1327, 1992
23. Aplan PD, Begley CG, Bertness VL, Nussmeier M, Ezquerra A, Coligan J, Kirsch IR: The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol 10:6426, 1990
24. Battey J, Moulding C, Taub R, Murphy W, Stewart T, Potter M, Lenoir G, Leder P: The human c-myc oncogene: Structural consequences of translocation resulting from chromosome translocation in B-lymphoid tumors. EMBO J 2:2375, 1983
25. Chervinsky DS, Sait SNJ, Nowak NJ, Shows TB, Aplan PD: Complex MLL rearrangement in a patient with T-cell acute lymphoblastic leukemia. Genes Chromosom Cancer 14:76, 1995
26. Begley CG, Aplan PD, Davey MP, Nakahara K, Tchorz K, Kurtzberg J, Hershfield M, Haynes BF, Cohen DI, Waldmann TA, Kirsch IR: Chromosomal translocation in a human leukemic stemcell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 86:2031, 1989
27. Morgan GJ, Cotter F, Katz FE, Ridge SA, Domer P, Korsemeyer S, Wiedemann LM: Breakpoints at 11q23 in infant leukemias with the t(11;19)(q23;p13) are clustered. Blood 80:2172, 1992
28. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, LeBeau MM, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute myeloid and acute lymphoblastic leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909, 1993
29. Mamuris Z, Prieur M, Dutrillaux B, Aurias A: The chemotherapeutic drug melphalan induces breakage of chromosomes regions rearranged in secondary leukemia. Cancer Genet Cytogenet 37:65, 1989
30. Gu Y, Alder H, Nakamura T, Schichman SA, Prasad R, Canaani, Saito H, Croce CM, Canaani E: Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res 54:2327, 1994
31. Spitzner JR, Muller MT: A consensus sequence for cleavage by vertebrate DNA topoisomerase II. Nucleic Acids Res 16:5533, 1988
32. Pommier Y, Orr A, Kohn KW, Riou J-F: Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene. Cancer Res 52:3125, 1992
33. Walker P, Smith C, Youdale T, Leblanc J, Whitfield J, Sikorska M: Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res 51:1078, 1991
34. Jackson DA, Dickinson P, Cook PR: The size of chromatin loops in HeLa cells. EMBO J 9:567, 1990
35. Berrios M, Osheroff N, Fisher PA: In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. Proc Natl Acad Sci USA 82:4142, 1985
36. Charron M, Hancock R: Chromosome recombination and defective genome segration induced in Chinese hamster cells by the topoisomerase II inhibitor VM-26. Chromosoma 100:97, 1991
37. Razin SV, Petrov P, Hancock R: Precise localization of the α-globin gene cluster within one of the 20- to 300-kilobase DNA fragments released by cleavage of chicken chromosomal DNA at topoisomerase II sites in vivo: Evidence that the fragments are DNA loops or domains. Proc Natl Acad Sci USA 88:8515, 1991
38. Felix CA, Lange BJ, Hosler MR, Fertala J, Bjornsti M-A: Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res 55:4287, 1995
39. Kas E, Laemmli UK: In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. EMBO J 11:705, 1992
40. Chow K, King C, Ross W: Abrogation of etoposide-mediated cytotoxicity by cycloheximide. Biochem Pharmacol 37:1117, 1988
41. Schneider E, Lawson P, Ralph R: Inhibition of protein synthesis reduces the cytotoxicity of 4′-(9-acridinylamino)methanesufon-m-aniside without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line. Biochem Pharmacol 38:263, 1989
42. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M: Apoptic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679, 1993